Morgann completed her BS and MS in Biomedical Engineering at Northwestern University. While at Northwestern, Morgann worked two years as a student researcher in the laboratory of Dr. Patrick Kiser, focusing on developing drug delivery systems for infectious diseases and women’s health. Morgann specifically worked on projects in formulation science as well as manufacturing and design engineering in order to produce medical devices for long-acting protection against HIV. Morgann joined cc-TDI as a Biomedical Engineering Fellow in July 2016 investigating medulloblastoma, the most common malignant brain tumor in children, with the goal of discovering novel targets and therapies.
Dr. Charles Keller, MD
Scientific Director
